Abstract
During recent years clinical trials have shown that human leukocyte Interferon (HuIFN-α) may be useful in the treatment of cancer, but very little has been done concerning the possible use of human fibroblast Interferon (HuIFN-β). Treuner et al.1 recently reported the successful treatment of a nasopharyngeal carcinoma with HuIFN-β: in the course of IFN-therapy a HuIFN-β neutralizing activity appeared in the serum of this patient. We report here that such activity is due to IgG antibodies—this study is the first to present evidence for antigenicity of IFN in a homologous system.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Treuner, J. et al. Lancet i, 817–818 (1980).
Berg, K., Ogburn, C. A., Paucker, K., Mogensen, K. E. & Cantell, K. J. Immun. 114, 640–644 (1975).
Paucker, K. & Cantell, K. Virology 18, 154–147 (1962).
Levy-Koenig, R. E., Mundy, M. J. & Paucker, K. J. Immun. 104, 785–790 (1970).
Strander, H., Cantell, K., Carlstrom, G. & Jakobson, P. A. J. natn. Cancer. Inst. 51, 733–739 (1973).
Desmyter, J. et al. Lancet ii, 645–648 (1976).
Treuner, J. et al. J. Interferon Res. (submitted).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Vallbracht, A., Treuner, J., Flehmig, B. et al. Interferon-neutralizing antibodies in a patient treated with human fibroblast interferon. Nature 289, 496–497 (1981). https://doi.org/10.1038/289496a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/289496a0
This article is cited by
-
Anti-cytokine autoantibodies: mechanistic insights and disease associations
Nature Reviews Immunology (2024)
-
Recombinant IFN-γ1b Treatment in a Patient with Inherited IFN-γ Deficiency
Journal of Clinical Immunology (2024)
-
Human genetic and immunological determinants of critical COVID-19 pneumonia
Nature (2022)
-
Harnessing Type I IFN Immunity Against SARS-CoV-2 with Early Administration of IFN-β
Journal of Clinical Immunology (2021)
-
Induction of interleukin-6 (IL-6) autoantibodies through vaccination with an engineered IL-6 receptor antagonist
Nature Biotechnology (1997)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.